These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25539920)

  • 1. Sequence-dependent off-target inhibition of TLR7/8 sensing by synthetic microRNA inhibitors.
    Sarvestani ST; Stunden HJ; Behlke MA; Forster SC; McCoy CE; Tate MD; Ferrand J; Lennox KA; Latz E; Williams BR; Gantier MP
    Nucleic Acids Res; 2015 Jan; 43(2):1177-88. PubMed ID: 25539920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Off-Target Effects of miRNA Inhibitors on Innate Immune Toll-Like Receptors.
    Pépin G; Ferrand J; Gantier MP
    Methods Mol Biol; 2017; 1517():127-135. PubMed ID: 27924479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists.
    Alharbi AS; Garcin AJ; Lennox KA; Pradeloux S; Wong C; Straub S; Valentin R; Pépin G; Li HM; Nold MF; Nold-Petry CA; Behlke MA; Gantier MP
    Nucleic Acids Res; 2020 Jul; 48(13):7052-7065. PubMed ID: 32544249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2'-O-methyl-modified RNAs act as TLR7 antagonists.
    Robbins M; Judge A; Liang L; McClintock K; Yaworski E; MacLachlan I
    Mol Ther; 2007 Sep; 15(9):1663-9. PubMed ID: 17579574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence-dependent inhibition of cGAS and TLR9 DNA sensing by 2'-O-methyl gapmer oligonucleotides.
    Valentin R; Wong C; Alharbi AS; Pradeloux S; Morros MP; Lennox KA; Ellyard JI; Garcin AJ; Ullah TR; Kusuma GD; Pépin G; Li HM; Pearson JS; Ferrand J; Lim R; Veedu RN; Morand EF; Vinuesa CG; Behlke MA; Gantier MP
    Nucleic Acids Res; 2021 Jun; 49(11):6082-6099. PubMed ID: 34057477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Inhibitory Activity of Oligonucleotides on TLR7 Sensing.
    Ferrand J; Gantier MP
    Methods Mol Biol; 2016; 1390():79-90. PubMed ID: 26803623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier.
    Lennox KA; Owczarzy R; Thomas DM; Walder JA; Behlke MA
    Mol Ther Nucleic Acids; 2013 Aug; 2(8):e117. PubMed ID: 23982190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient and specific inhibition of plant microRNA function by anti-microRNA oligonucleotides (AMOs) in vitro and in vivo.
    He L; Xie M; Huang J; Zhang T; Shi S; Tang T
    Plant Cell Rep; 2016 Apr; 35(4):933-45. PubMed ID: 26792284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A direct comparison of anti-microRNA oligonucleotide potency.
    Lennox KA; Behlke MA
    Pharm Res; 2010 Sep; 27(9):1788-99. PubMed ID: 20424893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an optimized 2'-
    Schmitt FCF; Freund I; Weigand MA; Helm M; Dalpke AH; Eigenbrod T
    RNA; 2017 Sep; 23(9):1344-1351. PubMed ID: 28576825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity.
    Vlach J; Bender AT; Przetak M; Pereira A; Deshpande A; Johnson TL; Reissig S; Tzvetkov E; Musil D; Morse NT; Haselmayer P; Zimmerli SC; Okitsu SL; Walsky RL; Sherer B
    J Pharmacol Exp Ther; 2021 Mar; 376(3):397-409. PubMed ID: 33328334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of TLR7/8 small RNA antagonists.
    Sioud M
    Methods Mol Biol; 2010; 629():387-94. PubMed ID: 20387163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR7 is involved in sequence-specific sensing of single-stranded RNAs in human macrophages.
    Gantier MP; Tong S; Behlke MA; Xu D; Phipps S; Foster PS; Williams BR
    J Immunol; 2008 Feb; 180(4):2117-24. PubMed ID: 18250417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-nucleotide Modification of Anti-miRNA Oligonucleotides.
    Lennox KA; Vakulskas CA; Behlke MA
    Methods Mol Biol; 2017; 1517():51-69. PubMed ID: 27924473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of 2,6-Diaminopurines into Serinol Nucleic Acid Improves Anti-miRNA Performance.
    Kamiya Y; Donoshita Y; Kamimoto H; Murayama K; Ariyoshi J; Asanuma H
    Chembiochem; 2017 Oct; 18(19):1917-1922. PubMed ID: 28748559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
    Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
    PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-miRNA oligonucleotides: A comprehensive guide for design.
    Lima JF; Cerqueira L; Figueiredo C; Oliveira C; Azevedo NF
    RNA Biol; 2018 Mar; 15(3):338-352. PubMed ID: 29570036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Novel Small Molecule Dual Inhibitors Targeting Toll-Like Receptors
    Padilla-Salinas R; Anderson R; Sakaniwa K; Zhang S; Nordeen P; Lu C; Shimizu T; Yin H
    J Med Chem; 2019 Nov; 62(22):10221-10244. PubMed ID: 31687820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
    Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G
    Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative relationship between chemical properties and bioactivities of anti-microRNA oligonucleotides targeted to tumor-associated microRNA-21.
    Nagahama K; Iseda K; Kawano D; Kawakami J
    Biochimie; 2017 Jun; 137():124-131. PubMed ID: 28302473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.